In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV

被引:5
|
作者
Udofia, Inemesit A. [1 ]
Gbayo, Kofoworola O. [1 ]
Oloba-Whenu, Oluwakemi A. [1 ]
Ogunbayo, Taofeek B. [1 ]
Isanbor, Chukwuemeka [1 ]
机构
[1] Univ Lagos, Dept Chem, Lagos, Nigeria
关键词
COVID-19; Molecular docking; Antiviral drugs; Binding energy; Ligand binding interaction; ANTIVIRAL DRUGS;
D O I
10.1007/s13721-021-00299-2
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
An outbreak of a cluster of viral pneumonia cases, subsequently identified as coronavirus disease 2019 (COVID-19), due to a novel SARS-CoV-2 necessitates an urgent need for a vaccine to prevent infection or an approved medication for a cure. In our in silico molecular docking study, a total of 173 compounds, including FDA-approved antiviral drugs, with good ADME descriptors, and some other nucleotide analogues were screened. The results show that these compounds demonstrate strong binding affinity for the residues at the active sites of RNA-dependent RNA-polymerase (RdRp) modelled structures and Chymotrypsin-like cysteine protease (3CLpro) of the HCoV proteins. Free energies (AG's) of binding for SARS-CoV-2 and SARS-CoV RdRp range from - 5.4 to - 8.8 kcal/mol and - 4.9 to - 8.7 kcal/mol, respectively. Also, SARS-CoV-2 and SARS-CoV 3CLpro gave AG values ranging from - 5.1 to - 8.4 kcal/mol and - 5.5 to - 8.6 kcal/mol, respectively. Interesting results are obtained for ivermectin, an antiparasitic agent with broad spectrum activity, which gave the highest binding energy value (- 8.8 kcal/mol) against the 3CLpro of SARS-CoV-2 and RdRps of both SARS-CoV and SARS-CoV-2. The reason for such high binding energy values is probably due to the presence of hydroxy, methoxy and sugar moieties in its structure. The stability of the protein-ligand complexes of polymerase inhibitors considered in this investigation, such as Sofosbuvir, Remdesivir, Tenofovir, Ribavirin, Galidesivir, 5c3, 5h1 and 7a1, show strong to moderate hydrogen bonding and hydrophobic interactions (pi-pi stacked, pi-pi T-shaped, pi-sigma and pi-alkyl). The stability provided from such interactions translate into greater antiviral activity or inhibitory effect of the ligands. Assessment of the average free energies of binding of the FDA approved drugs are highly comparable for conformers of a particular inhibitor, indicating similar modes of binding within the pockets.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Repurposed drug molecules targeting NSP12 protein of SARS-CoV-2: An in-silico study
    Sharma, Bhawna
    Angel, Bennet
    Naik, Vankadoth Umakanth
    Angel, Annette
    Joshi, Vinod
    Shareef, Bm
    Singh, Neha
    Khan, Ambreen Shafaat
    Khaneja, Poorna
    Barthwal, Shilpa
    Joshi, Ramesh
    Peer, Nuzhat Maqbool
    Yadav, Kiran
    Tomar, Komal
    Singh, Satendra Pal
    AIMS MOLECULAR SCIENCE, 2023, 10 (04): : 322 - 342
  • [22] Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2
    Pokhrel, Rudramani
    Chapagain, Prem
    Siltberg-Liberles, Jessica
    JOURNAL OF MEDICAL MICROBIOLOGY, 2020, 69 (06) : 864 - 873
  • [23] Kaempferol as a novel inhibitor of SARS-CoV-2 RNA-dependent RNA polymerase
    Medoro, Alessandro
    Benedetti, Francesca
    Intrieri, Mariano
    Jafar, Tassadaq Hussain
    Ali, Sawan
    Trung, Truong Tan
    Passarella, Daniela
    Ismail, Saba
    Zella, Davide
    Scapagnini, Giovanni
    Davinelli, Sergio
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024,
  • [24] Targeting the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) with synthetic/designer unnatural nucleoside analogs: an in silico study
    Subhendu Sekhar Bag
    Sayantan Sinha
    Soumya Dutta
    Hirak Jyoti Baishya
    Suravi Paul
    Journal of Molecular Modeling, 2023, 29
  • [25] Targeting the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) with synthetic/designer unnatural nucleoside analogs: an in silico study
    Bag, Subhendu Sekhar
    Sinha, Sayantan
    Dutta, Soumya
    Baishya, Hirak Jyoti
    Paul, Suravi
    JOURNAL OF MOLECULAR MODELING, 2023, 29 (12)
  • [26] Potential of turmeric-derived compounds against RNA-dependent RNA polymerase of SARS-CoV-2: An in-silico approach
    Singh, Rahul
    Bhardwaj, Vijay Kumar
    Purohit, Rituraj
    COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 139
  • [27] Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2
    Bekheit, Mohamed S.
    Panda, Siva S.
    Girgis, Adel S.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 252
  • [28] SARS-CoV-2 RNA-dependent RNA polymerase as a target for high-throughput drug screening
    Wu, Jiahui
    Chen, Zhiqiang
    Han, Xue
    Chen, Qiaoqiao
    Wang, Yintao
    Feng, Tingting
    FUTURE VIROLOGY, 2023, : 51 - 62
  • [29] In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs
    Mondal, Sunil Kanti
    Mukhoty, Samyabrata
    Kundu, Himangsu
    Ghosh, Subhajit
    Sen, Madhab Kumar
    Das, Suvankar
    Brogi, Simone
    COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 135
  • [30] Effects of natural RNA modifications on the activity of SARS-CoV-2 RNA-dependent RNA polymerase
    Petushkov, Ivan
    Esyunina, Daria
    Kulbachinskiy, Andrey
    FEBS JOURNAL, 2023, 290 (01) : 80 - 92